The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential investors.

We reveal the 16 best ASX 200 large-cap stocks for share price growth last year. The post Which ASX 200 large-cap shares ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential investors.

In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant ...

Brokerage house InCred is bullish over India’s cement industry and expects mid-single digit growth yoy in 3QFY25F. InCred ...

Heading into the end of the year, the investment market has given us and our clients plenty to be thankful for Even so, more ...

Read here for an analysis of actively managed ETF BRNY, highlighting its factor-rotation strategy, recent performance, and ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

The change is perceptible in all corners of the market. But let’s start with equities. In the months running up to the ...

Despite muted equity market performance during the month of December, inflows in open-ended equity funds stayed in the ...

The sectoral and thematic fund category, which witnessed the closing of 12 new fund offerings (NFOs) in December, contributed ...

Discussing high valuations in the tech sector, particularly for large-cap stocks trading at forward earnings multiples ...